WBP2 is an emerging tumor protein that functions in different oncogenic signaling pathways, such as the ER/PR, EGFR, PI3K, Hippo, and Wnt signaling pathways (Tabatabaeian et al., 2020), and WBP2 has gained attention as a potential drug target. This evidence concerns the gene EGFR and neoplasm.